Format

Send to

Choose Destination
Molecules. 2016 Mar 24;21(4):402. doi: 10.3390/molecules21040402.

A Series of Oleanolic Acid Derivatives as Anti-Hepatitis B Virus Agents: Design, Synthesis, and in Vitro and in Vivo Biological Evaluation.

Author information

1
School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 100102, China. ywq3226925@163.com.
2
School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 100102, China. zcz920418@163.com.
3
School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 100102, China. libimegan@163.com.
4
School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 100102, China. xu.xin@vip.126.com.
5
School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 100102, China. mimi1111202@sina.com.
6
Department of Pharmacology, Xuanwu Hospital of Capital Medical University, Key Laboratory for Neurodegenerative Diseases of Ministry of Education, Beijing 100053, China. gszy2003@163.com.
7
School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 100102, China. chufhao@163.com.
8
School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 100102, China. weichenxubing@126.com.
9
School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 100102, China. renjian2008333@163.com.
10
School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 100102, China. wpl581@126.com.
11
School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 100102, China. leihaimin@126.com.

Abstract

A series of oleanolic acid derivatives were synthesized by diverse reactions, including the introduction of conjugated alkadiene and epoxy ring moieties formed by means of photosensitized oxidation. Eosin Y was used as photosensitizer during this process. Next the cytotoxicity of the products was evaluated on HepG2.2.15 cells to determine the appropriate treatment concentration for the subsequent experiments. Most of the OA derivatives exhibited anti-HBV antigens secretion activity in HepG2.2.15 cells. Among the tested compounds, OA-4 (3.13 µg/mL) showed significant activity against the secretion of HBsAg, HBeAg, and HBV DNA replication with inhibitory ratios of 90.52% ± 1.78%, 31.55% ± 3.65%, and 94.57% ± 3.11% after 6 days, respectively. Besides, OA-4 was further investigated in a duck model with DHBV infection. When OA-4 was administered at a dosage of 500 mg/kg, the results revealed a significant inhibitory effects of DHBV at 19.94% ± 2.87%, 28.80% ± 3.62% and 29.25% ± 2.65% at days 5, 10, and 3 after the cessation of OA-4 treatment, respectively. It's worth noting that OA-4 is superior to lamivudine in the inhibition of rebound of viral replication rate. The structure-activity relationships of OA derivatives had been preliminary discussed, which should be useful to explore further novel anti-HBV agents.

KEYWORDS:

anti-hepatitis B virus; eosin Y; epoxy ring; oleanolic-acid derivatives; virus recrudescence

PMID:
27023498
PMCID:
PMC6273212
DOI:
10.3390/molecules21040402
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Multidisciplinary Digital Publishing Institute (MDPI) Icon for PubMed Central
Loading ...
Support Center